Tag: pharmaceuticals

  • Injected Drug Forms Anti-Cancer Nanoparticles in Tumors

    15 March 2016. Medical researchers developed a drug delivery technique that in lab mice forms anti-cancer nanoparticles inside metastatic tumors, promising much more potent cancer treatments. The team led by Mauro Ferrari and Haifa Shen at Houston Methodist Research Institute in Texas published its findings in yesterday’s (14 March) issue of Nature Biotechnology; paid subscription…

  • Beta Cell Patch Designed to Control Blood Glucose Levels

    14 March 2016. A patch device made of beta cells — the cells that produce insulin — was shown to produce insulin on demand in lab mice induced with diabetes. A team from the biomedical engineering department jointly hosted by University of North Carolina in Chapel Hill and North Carolina State University in Raleigh published…

  • Biomarker Profiles Shown to Improve Ovarian Cancer Survival

    14 March 2016. A clinical trial of people with ovarian cancer shows patients receiving treatments matching their particular molecular profiles survived an average of 9 months longer than those receiving one or more drugs not matching their biomarkers. Results of the study, conducted by Caris Life Sciences at 6 cancer care hospitals in the U.S.…

  • Hydrogel Injection Tested to Treat Advanced Artery Disease

    9 March 2016. A biomedical engineering team developed an injected hydrogel for advanced cases of peripheral artery disease that in lab animals improved blood flow and muscles in affected limbs. Researchers from University of California in San Diego, led by bioengineering professor Karen Christman, published their findings earlier this year in the Journal of the…

  • Allergy Drug Shown to Allow Eating Small Peanut Amounts

    7 March 2016. A new drug was shown in a clinical trial to allow most children and teens with food allergies to eat peanuts in small quantities. The results of the intermediate-stage trial were reported yesterday at the annual meeting of American Academy of Allergy, Asthma and Immunology in Los Angeles. Allergies to peanuts and other…

  • Gene Editing Creates Pigs Resilient to African Virus

    23 February 2016. University and industry researchers edited the genomes of domesticated pigs to create a variety better able to withstand a deadly tick-borne virus. The team from University of Edinburgh and the biotechnology companies Sangamo BioSciences and Genus plc published its findings in yesterday’s (22 February) issue of the journal Scientific Reports. The team…

  • Breast Cancer Academic Research Program Launched

    23 February 2016. Breast Cancer Research Foundation in New York began a new initiative to attract more academic researchers to take part in clinical trials of cancer therapies. The group is starting its Drug Research Collaborative, with a $15 million contribution from drug maker Pfizer, that is also granting research access to its cancer drug…

  • Duchenne-Related Stem Cell Heart Therapy Trial Underway

    22 February 2016. An early clinical trial testing a stem cell therapy for heart disease among individuals with Duchenne muscular dystrophy treated its first enrolled patient. The trial is conducted by Capricor Inc. in Los Angeles, developer of the treatments code-named CAP-1002, for cardiomyopathy or heart failure related to Duchenne muscular dystrophy. Duchenne muscular dystrophy is…

  • Pain Medication Given FDA Breakthrough Tag

    22 February 2016. A new drug to treat moderate to severe pain, now in clinical trials, received a breakthrough designation from the U.S. Food and Drug Administration. The drug, oliceridine, is made by Trevena Inc. in King of Prussia, Pennsylvania. Oliceridine addresses the same pain signals as opioid drugs that affect areas of the brain…

  • FDA Approves New Epilepsy Drug

    19 February 2016. The U.S. Food and Drug Administration approved a molecular therapy for epilepsy designed to supplement treatments for partial-onset seizures. The drug is brivaracetam, marketed as Briviact by UCB, a pharmaceutical company headquartered in Brussels, Belgium. Epilepsy is a neurological disorder where nerve cell activity in the brain is disturbed, causing seizures with symptoms…